Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.14 USD
Change Today -0.0025 / -1.79%
Volume 50.2K
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

135 Beaver Street

Waltham, MA 02452

United States

Phone: 781-398-0700

Fax: 781-398-0720

Interleukin Genetics, Inc., a health company, develops genetic tests to provide information to manage health and specific health risks. The company’s business focuses on personalized health, by providing genetic tests that are actionable and provides clinical value. Its tests are made available through healthcare providers, through marketing partners or, for some of its tests, directly to end users. The company has patents covering the use of certain gene variations and specific combinations of gene variations for a number of common chronic diseases and conditions. The company’s genetic tests that are being commercialized are: PerioPredict: This genetic test analyzes genetic variations associated with inflammation and identifies individuals who are at increased risk for more severe periodontal disease. In 2013, the company announced the introduction of PerioPredict, its next-generation version of the PST genetic test. The genetic test utilizes an expansion of previous genetic markers that cover all major ethnic groups. Weight Management Genetic Test: This test determines whether a low fat, low carbohydrate or balanced diet may be best and whether normal or vigorous exercise is needed to most lose existing body fat. This test is marketed under the company’s Inherent Health brand. The company’s Weight Management Genetic Test helps take the guesswork out of finding an effective diet and exercise solution by revealing actionable steps to achieve weight goals based on genetics. Bone Health Genetic Test: This test is designed to identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density associated with osteoporosis. This test is marketed under the company’s Inherent Health brand. The test identifies a single nucleotide polymorphism (SNP) in each of three genes involved in processes that affect bone; estrogen receptor alpha (ER1 Xba1), vitamin D receptor, and interleukin-1 (IL-1). Heart Health Genetic Test: This test is designed to identify genetic predisposition to excess inflammation, which is a risk factor for heart attack. This test is marketed under the company’s Inherent Health brand. The test identifies three SNPs in two genes involved in inflammation, IL-1 alpha and IL-1 beta. Certain IL-1 variations are associated with increased inflammation. Nutritional Needs Genetic Test: This test is designed to identify DNA variations in genes crucial to B-vitamin metabolism and the ability to manage oxidative stress. This test is marketed under the company’s Inherent Health brand. The test identifies the presence or absence of human genotypic markers methylenetetrahydrofolate reductase and transcobalamin II involved in vitamin B metabolism and markers superoxide dismutase 2, glutathione S-transferase 1 deletions, paraoxonase 1, X-ray repair cross complementing group 1 in response to oxidative stress. Wellness Select Genetic Test: This allows buyers to purchase any combination of Inherent Health genetic tests. This is marketed under the company’s Inherent Health brand. The company has an amended and restated preferred participation agreement with Renaissance Health Services Corporation, the exclusive distributor of the Delta Dental brand in eight states, with respect to reimbursement for its PerioPredict test. The company markets its Inherent Health brand of genetic assessment tests primarily through its commercial relationships with Alticor affiliated companies, such as Amway. Genetic Tests The company focuses its research, development and commercialization efforts on identifying combinations of SNP variations for which there is biological understanding for certain uses associated with inflammation or metabolic disease. The company worked with various universities, including the University of Sheffield in the United Kingdom to identify various SNPs and other factors that influence the body’s inflammatory response. Its scientific advisory board includes Sir Gordon Duff, one of the pioneers in the understanding of the role that genetics plays in inflammatory disease pathways. In addition, the company has conducted clinical studies for various indicatio

Page 12Next Page

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILIU:US $0.14 USD -0.0025

ILIU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ILIU.
View Industry Companies

Industry Analysis


Industry Average

Valuation ILIU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.0x
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERLEUKIN GENETICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at